Quest Diagnostics Inc vs Taskus Inc — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.95B), while Taskus Inc trades at $5.61 (market cap $514.67M). The key difference: Quest Diagnostics Inc is far larger — about 44.6× Taskus Inc's market cap, and Quest Diagnostics Inc pays a 1.66% dividend while Taskus Inc pays none. Which is the better fit depends on your goals.
| DGX | TASK | |
|---|---|---|
Market Cap | $22.95B | $514.67M |
Sector | Health | Technology |
52-Week High | $216.02 | $18.21 |
52-Week Low | $166.42 | $4.57 |
Enterprise Value | $28.97B | $910.37M |
Dividend Yield | 1.66% | — |
Trailing returns across standard periods
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →TaskUs Inc is a provider of outsourced digital services and next-generation customer experience to innovative and disruptive technology companies. It serves clients in the fastest-growing sectors, including social media, e-commerce, gaming, streaming media, food delivery and ridesharing, HiTech, FinTech and HealthTech.
Read more on TASK →